Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Breast Cancer |
Free Subscription
1 Am J Surg |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Breast Cancer is free of charge.
The impact of COVID-19 on patients diagnosed with melanoma, breast, and
colorectal cancer.
Am J Surg. 2023 Sep 29:S0002-9610(23)00496-8. doi: 10.1016/j.amjsurg.2023.
PubMed
Abstract available
ASO Author Reflections: Considerations in the Debate on Sentinel Node Biopsy in
Older Patients with ER+/Her2- Breast Cancer.
Ann Surg Oncol. 2024 Feb 21. doi: 10.1245/s10434-024-15095.
PubMed
ASO Visual Abstract: Surgical Management of the Axilla in HR+/HER2-Breast Cancer
in the Z1071 Era: A Propensity-Score Matched Analysis of the National Cancer
Database.
Ann Surg Oncol. 2024 Feb 19. doi: 10.1245/s10434-024-15063.
PubMed
Oncological Safety of Skipping Axillary Lymph Node Dissection in Patients with
Clinical N0, Sentinel Node-Positive Breast Cancer Undergoing Total Mastectomy.
Ann Surg Oncol. 2024 Feb 17. doi: 10.1245/s10434-024-15049.
PubMed
Abstract available
ASO Visual Abstract: Upgrade Rates and Breast Cancer Development Among Germline
Pathogenic Variant Carriers with High-Risk Breast Lesions.
Ann Surg Oncol. 2024 Feb 16. doi: 10.1245/s10434-024-15067.
PubMed
Using a combination of superb microvascular imaging and other auxiliary
ultrasound techniques to increase the accuracy of gray-scale ultrasound for
breast masses.
BMC Cancer. 2024;24:224.
PubMed
Abstract available
Central nervous system metastases in breast cancer patients with germline BRCA
pathogenic variants compared to non-carriers: a matched-pair analysis.
BMC Cancer. 2024;24:219.
PubMed
Abstract available
Comment on "Pathological complete response, category change, and prognostic
significance of HER2-low breast cancer receiving neoadjuvant treatment: a
multicenter analysis of 2489 cases".
Br J Cancer. 2024 Feb 20. doi: 10.1038/s41416-024-02616.
PubMed
Outcomes of whole breast radiation therapy in Asian breast cancer patients with
prior cosmetic implants.
Breast Cancer. 2024 Feb 18. doi: 10.1007/s12282-024-01547.
PubMed
Abstract available
Clinicopathological Features and Treatment Outcomes of Male Breast Cancer in
Pakistani Population: A 10-Year Retrospective Cross-Sectional Study.
Breast Cancer (Auckl). 2024;18:11782234241233120.
PubMed
Abstract available
The prostate-specific membrane antigen holds potential as a vascular target for
endogenous radiotherapy with [(177)Lu]Lu-PSMA-I&T for triple-negative breast
cancer.
Breast Cancer Res. 2024;26:30.
PubMed
Abstract available
Metabolic adaptation towards glycolysis supports resistance to neoadjuvant
chemotherapy in early triple negative breast cancers.
Breast Cancer Res. 2024;26:29.
PubMed
Abstract available
Identification of CD160-TM as a tumor target on triple negative breast cancers:
possible therapeutic applications.
Breast Cancer Res. 2024;26:28.
PubMed
Abstract available
Geographical distance predicts psychiatric treatment retention for Hispanic women
with comorbid major depression and breast cancer.
Breast Cancer Res Treat. 2024 Feb 20. doi: 10.1007/s10549-024-07250.
PubMed
Abstract available
Breast cancer diagnosed after age 70 years in Israeli BRCA1/BRCA2 pathogenic
sequence variant carriers: a single institution experience.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-023-07234.
PubMed
Abstract available
Time trends in real-world treatment patterns and survival in patients diagnosed
with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-023-07235.
PubMed
Abstract available
Preoperative factors that predict pathologic nodal involvement in early-stage
HER2+ breast cancer: selecting cT1cN0 patients for treatment with neoadjuvant
chemotherapy versus upfront surgery.
Breast Cancer Res Treat. 2024 Feb 21. doi: 10.1007/s10549-024-07251.
PubMed
Abstract available
CD24 negativity reprograms mitochondrial metabolism to PPARalpha and NF-kappaB-driven
fatty acid beta-oxidation in triple-negative breast cancer.
Cancer Lett. 2024 Feb 17:216724. doi: 10.1016/j.canlet.2024.216724.
PubMed
Abstract available
PRMT1 sustains de novo fatty acid synthesis by methylating PHGDH to drive
chemoresistance in triple-negative breast cancer.
Cancer Res. 2024 Feb 22. doi: 10.1158/0008-5472.CAN-23-2266.
PubMed
Abstract available
Inhibitory Impact Of Cinobufagin In Triple-Negative Breast Cancer Metastasis:
Involvements Of Macrophage Reprogramming Through Upregulated MME and Inactivated
FAK/STAT3 Signaling.
Clin Breast Cancer. 2024 Jan 26:S1526-8209(24)00025.
PubMed
Abstract available
Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer
Patients With 1-2 Sentinel Lymph Node Metastases.
Clin Breast Cancer. 2024 Jan 24:S1526-8209(24)00022.
PubMed
Abstract available
Selective CDK7 inhibition suppresses cell cycle progression and MYC signaling
while enhancing apoptosis in therapy-resistant estrogen receptor positive breast
cancer.
Clin Cancer Res. 2024 Feb 21. doi: 10.1158/1078-0432.CCR-23-2975.
PubMed
Abstract available
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy
Benefit in Hormone Receptor-positive Breast Cancer from the NRG Oncology/NSABP
B-42 Trial.
Clin Cancer Res. 2024 Feb 20. doi: 10.1158/1078-0432.CCR-23-1977.
PubMed
Abstract available
Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab
vedotin in a multiresistant HER2-positive breast cancer lung metastasis model.
Clin Exp Metastasis. 2024 Feb 17. doi: 10.1007/s10585-024-10278.
PubMed
Abstract available
Breast Cancer in Young Women: Is It Different? A Single-Center Retrospective
Cohort Study.
Clin Med Insights Oncol. 2024;18:11795549241228235.
PubMed
Abstract available
Evolution of HER2 expression between pre-treatment biopsy and residual disease
after neoadjuvant therapy for breast cancer.
Eur J Cancer. 2024;201:113920.
PubMed
Abstract available
Localization of contrast-enhanced breast lesions in ultrafast screening MRI using
deep convolutional neural networks.
Eur Radiol. 2024;34:2084-2092.
PubMed
Abstract available
Barriers and facilitators of artificial intelligence conception and
implementation for breast imaging diagnosis in clinical practice: a scoping
review.
Eur Radiol. 2024;34:2096-2109.
PubMed
Abstract available
Diagnostic capabilities of artificial intelligence as an additional reader in a
breast cancer screening program.
Eur Radiol. 2024 Feb 22. doi: 10.1007/s00330-024-10661.
PubMed
Abstract available
Real-world experience in Hispanic Patients with Breast Cancer and Brain
Metastases using different Prognostic Tools.
Int J Radiat Oncol Biol Phys. 2024 Feb 14:S0360-3016(24)00305.
PubMed
Abstract available
US Food and Drug Administration Approval Summary: Elacestrant for Estrogen
Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative,
ESR1-Mutated Advanced or Metastatic Breast Cancer.
J Clin Oncol. 2024 Feb 21:JCO2302112. doi: 10.1200/JCO.23.02112.
PubMed
Abstract available
Cancer risks among first-degree relatives of women with a genetic predisposition
to breast cancer.
J Natl Cancer Inst. 2024 Feb 14:djae030. doi: 10.1093.
PubMed
Abstract available
A guide for addressing sexual health in breast cancer patients.
J Surg Oncol. 2024 Feb 22. doi: 10.1002/jso.27602.
PubMed
Abstract available
Whole-Genome Sequencing Analysis of Male Breast Cancer Unveils Novel Structural
Events and Potential Therapeutic Targets.
Mod Pathol. 2024 Feb 16:100452. doi: 10.1016/j.modpat.2024.100452.
PubMed
Abstract available
Digital PCR quantification of ultrahigh ERBB2 copy number identifies poor breast
cancer survival after trastuzumab.
NPJ Breast Cancer. 2024;10:14.
PubMed
Abstract available
CDK4/6i-treated HR+/HER2- breast cancer tumors show higher ESR1 mutation
prevalence and more altered genomic landscape.
NPJ Breast Cancer. 2024;10:15.
PubMed
Abstract available
Cancer-associated fibroblasts rewire the estrogen receptor response in luminal
breast cancer, enabling estrogen independence.
Oncogene. 2024 Feb 22. doi: 10.1038/s41388-024-02973.
PubMed
Abstract available
LncRNA PRBC induces autophagy to promote breast cancer progression through
modulating PABPC1-mediated mRNA stabilization.
Oncogene. 2024 Feb 16. doi: 10.1038/s41388-024-02971.
PubMed
Abstract available
Predictive and prognostic biomarkers in breast tumours.
Pathology. 2024;56:186-191.
PubMed
Abstract available
TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER)
binding and ER target gene expression in luminal breast cancer cells.
PLoS Genet. 2024;20:e1011159.
PubMed
Abstract available
Unraveling the impact of a glyco-immune checkpoint in bone metastasis.
Proc Natl Acad Sci U S A. 2024;121:e2400499121.
PubMed
Screening Breast MRI Effectively Detects Early-Stage Breast Cancer in High-Risk
Patients without Prior History of Breast Cancer.
Radiol Imaging Cancer. 2024;6:e249005.
PubMed
Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and
Surveillance Modeling Network Estimates.
Radiology. 2024;310:e232658.
PubMed
Abstract available
LUMINA: Using molecular biomarkers to guide decision making for breast
radiotherapy.
Radiother Oncol. 2024;190:110074.
PubMed
Abstract available
Quality assurance of radiation therapy after breast-conserving surgery among
patients in the BOOG 2013-08 trial.
Radiother Oncol. 2024;191:110069.
PubMed
Abstract available
An open source auto-segmentation algorithm for delineating heart and
substructures - Development and validation within a multicenter lung cancer
cohort.
Radiother Oncol. 2024;191:110065.
PubMed
Abstract available
Omission of radiation therapy after breast-conserving surgery for biologically
favourable tumours in younger patients: The wrong answer to the right question.
Radiother Oncol. 2024;190:110045.
PubMed
Abstract available
Thank you for your interest in scientific medicine.